Synergistic Endometrial Ablation Systems

Publication ID: 24-11857248_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Endometrial Ablation Systems,” Published Technical Disclosure No. 24-11857248_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857248_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,248.

Summary of the Inventive Concept

The inventive concept integrates radio frequency-based endometrial ablation technology with advanced technologies like AI, IoT, blockchain, and nanomaterials to create more effective and personalized treatment systems.

Background and Problem Solved

The original patent disclosed methods and systems for endometrial ablation utilizing radio frequency. However, these systems lacked the ability to optimize treatment parameters, securely store patient data, and integrate with emerging technologies. The new inventive concept addresses these limitations by combining radio frequency ablation with synergistic technologies to enhance treatment outcomes and patient care.

Detailed Description of the Inventive Concept

The inventive concept encompasses four distinct systems and methods for endometrial ablation. The first system integrates a radio frequency generator with an artificial intelligence module to optimize treatment parameters based on real-time patient data, and a blockchain-based data storage system for secure patient record management. The second method utilizes an IoT-enabled sensor to monitor tissue temperature and adjust the radio frequency current flow accordingly. The third system incorporates a nanomaterial-based coating on the dielectric structure to enhance plasma formation and tissue interaction. The fourth method employs a machine learning module to predict treatment outcomes and adjust energy delivery parameters, with a cloud-based data analytics platform for tracking treatment efficacy and optimizing future treatments.

Novelty and Inventive Step

The new claims introduce the innovative combination of radio frequency ablation with AI, IoT, blockchain, nanomaterials, and machine learning technologies, which provides a synergistic effect that is not obvious from the original patent. The integration of these technologies enables personalized treatment, enhanced patient data management, and improved treatment outcomes, thereby constituting a novel and non-obvious inventive concept.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT sensor configurations, or alternative nanomaterials for the dielectric structure. Additionally, the system could be adapted for use in other medical applications, such as tumor treatment or cardiovascular procedures.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of women's health and minimally invasive surgical procedures. The integrated system could be marketed to hospitals, clinics, and medical research institutions, with potential for expansion into other medical specialties.

CPC Classifications

SectionClassGroup
A A61 A61B18/1485
A A61 A61B5/1076
A A61 A61B18/042
A A61 A61B2018/0022
A A61 A61B2018/00214
A A61 A61B2018/00559
A A61 A61B2018/00577
A A61 A61B2018/00666
A A61 A61B2018/147
A A61 A61B2090/064
A A61 A61B2218/008

Original Patent Information

Patent NumberUS 11,857,248
TitleMethods and systems for endometrial ablation utilizing radio frequency
Assignee(s)MINERVA SURGICAL, INC.